Blood Transfusion Clinical Trial
Official title:
Study on Patient Blood Management in Haematological Patients
Verified date | February 2019 |
Source | Universitaire Ziekenhuizen Leuven |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The investigators noticed a variable prescription of blood components to haematological patients in the hospital. This study will analyze the prescription and administration of blood components to Haematological patients (pre measurement). Based on these results guidelines on transfusion triggers will be updated and educated to the physicians and new ICT (information and communications technology) implementations will be added to the electronic order for blood components. The investigators hope to see afterwards (post measurement) a more stable prescription and administration of blood components and a more economic use of blood components.
Status | Suspended |
Enrollment | 700 |
Est. completion date | September 30, 2021 |
Est. primary completion date | September 30, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - all adult patients hospitalised at the haematology wards of the University Hospitals of Leuven (UZ Leuven) between 01/08/2017 and 31/07/2018 (pre measurement) and between between 01/08/2019 and 31/07/2020 (post measurement) Exclusion Criteria: - ambulatory patients - patients without blood transfusion administered in their hospitalised period - patients with no haematological illness that were hospitalised at the haematological wards |
Country | Name | City | State |
---|---|---|---|
Belgium | University Hospitals Leuven | Leuven |
Lead Sponsor | Collaborator |
---|---|
Universitaire Ziekenhuizen Leuven |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | how do haematologists prescribe blood components? | The investigators use a questionaire (15-20 questions) to evaluate how haematologists prescribe red blood cells and platelets. Do they analyze the haemoglobin and platelet count before and after each blood transfusion? Do they apply single unit policy for RBC and platelet transfusions? Which triggers are used for RBC and platelet transfusion? Which guidelines are followed? The investigators will send this questionnaire to all haematologists (including haematologists in training) in 2017 (premeasurement) and in 2019-2020 (postmeasurement). The investigators will also use data (which is already available in the patient files) about blood transfusion to evaluate the ordering and administration of blood components during 1 year. For which indication is blood ordered? Is the Haemoglobin level known before the order is send to the blood bank? |
up to 1 year pre measurement and up to 1 year post measurement | |
Secondary | what's the effect of the interventional phase? | The investigators will again use data (which is already available in the patient files) about blood transfusion to evaluate the ordering and administration of blood components during 1 year after the intervention phase. For which indication is blood ordered? Is the Haemoglobin level known before the order is send to the blood bank? Did the interventions lead to less prescriptions/administrations of blood components and more single unit transfusion? We will use SPSS for statistical analysis (frequencies, percentages and means, scatter plots) | up to 1 year (post measurement) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03651154 -
Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections
|
N/A | |
Completed |
NCT01136590 -
Multicenter, Randomized Placebo-controlled Clinical Trial to Evaluate the Effect of Perioperative Use of Tranexamic Acid on Transfusion Requirements and Surgical Bleeding in Major Spine Surgery
|
Phase 4 | |
Completed |
NCT00097006 -
Retrovirus Epidemiology Donor Study-II (REDS-II)
|
N/A | |
Completed |
NCT00005303 -
Effectiveness of AIDS Antibody Screening
|
N/A | |
Completed |
NCT00005319 -
Epidemiologic Studies of Blood Use in the United States - SCOR in Transfusion Medicine
|
N/A | |
Completed |
NCT00005301 -
Transfusion Safety Study (TSS)
|
N/A | |
Completed |
NCT00000581 -
Granulocyte Transfusion Study
|
Phase 3 | |
Completed |
NCT04089865 -
Oral Versus Intravenous Tranexamic Acid
|
Phase 4 | |
Completed |
NCT02968654 -
TRansfusion Strategies in Acute Brain INjured Patients
|
N/A | |
Enrolling by invitation |
NCT06019364 -
Transfusion of Whole Blood in Acute Bleeding
|
||
Completed |
NCT04911413 -
Comparison of Three Tranexamic Acid Dose Regimens in Patients Undergoing Cardiac Valve Surgery
|
Phase 4 | |
Completed |
NCT03727230 -
RhD+ Blood Transfusion to Asian-type DEL Recipients
|
N/A | |
Recruiting |
NCT06102590 -
Oxygen Extraction-guided Transfusion
|
N/A | |
Completed |
NCT00400192 -
Transfusion-Associated Microchimerism in Individuals Receiving a Blood Transfusion After a Traumatic Injury
|
N/A | |
Completed |
NCT00000593 -
Viral Activation Transfusion Study (VATS)
|
N/A | |
Completed |
NCT05627544 -
Blood Transfusion Applications in Hip Replacements
|
||
Completed |
NCT05581238 -
Validation of a Red Blood Cell Transfusion Prediction Model in a Low Transfusion Rate Population.
|
||
Not yet recruiting |
NCT03429790 -
Cell Salvage During Caesarean Section (CSCS)
|
N/A | |
Completed |
NCT00822588 -
Comparison in Need for Bank Blood Between Patients Undergoing Total Hip Surgery That Either Receive Their Own Blood Back or Not
|
N/A | |
Withdrawn |
NCT00269971 -
A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery.
|
Phase 3 |